PRESS RELEASE published on 11/01/2023 at 01:15, 1 year ago Alphinat Announces on Tuesday, October 31, 2023, Trading in the Company's Securities will be Suspended for Failure to Maintain Exchange Requirements
PRESS RELEASE published on 10/26/2023 at 21:30, 1 year ago Alphinat Announces Three New Professional Services Contracts for Public Sector
PRESS RELEASE published on 10/03/2023 at 03:13, 1 year 1 month ago Resignation of All Its External Directors From the Board of Directors & Resignation of External Audit Firm
PRESS RELEASE published on 08/08/2023 at 15:55, 1 year 3 months ago Alphinat Inc. Announces the Appointment of Ms. Rachel Porteous to Alphinat Inc. Board of Directors
PRESS RELEASE published on 08/03/2023 at 15:45, 1 year 3 months ago Alphinat Announces a Profit Before Non-Cash Charges of $21,937 and a Net Loss to $(5,848) for Fiscal 3rd Quarter Ended May 31, 2023
PRESS RELEASE published on 07/11/2023 at 04:00, 1 year 4 months ago Alphinat Announces LIVEaiASSIST in BETA Release, Delivery of GHGR for Province and Options Issued
PRESS RELEASE published on 04/28/2023 at 01:40, 1 year 6 months ago Alphinat Announces a Reduction in Net Loss to $(19,430) for Fiscal 2nd Quarter Ended February 28, 2023
PRESS RELEASE published on 03/06/2023 at 16:10, 1 year 8 months ago Alphinat Announces the Election of Eric David to Chairperson of Alphinat Board of Directors
PRESS RELEASE published on 01/21/2023 at 02:15, 1 year 10 months ago Alphinat Announces a Profit of $9,919 for Fiscal Quarter Ended November 30, 2022
Published on 11/21/2024 at 13:30, 24 minutes ago AirIQ Announces September 30, 2024 Quarterly Results Company Reports Double-Digit Growth in Recurring Revenue
Published on 11/21/2024 at 13:30, 24 minutes ago Datametrex Secures Additional P.O. Approx $250K for IT Services
Published on 11/21/2024 at 13:00, 54 minutes ago Aclara Secures Funding from Corfo's Innovation High-Tech Program for Artificial Intelligence Project
Published on 11/21/2024 at 13:00, 54 minutes ago Telomir Pharmaceuticals Confirms Age Reversal, Increased Longevity and Improved Healthspan in Groundbreaking Preclinical Study with Telomir-1
Published on 11/21/2024 at 13:00, 54 minutes ago Toggle3D.ai Rebrands as FOTOgpt.ai to Usher in a New Age of AI-Powered Photography
Published on 11/21/2024 at 12:35, 1 hour 19 minutes ago audius with successful third quarter 2024 - total revenue grows by +9.2% and EBITDA by +14.6
Published on 11/21/2024 at 12:15, 1 hour 39 minutes ago Hardman & Co Investor Forum Research on Shield Therapeutics (STX): Proactive cash management to cashflow-breakeven
Published on 11/21/2024 at 06:58, 6 hours 56 minutes ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 18 hours 34 minutes ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 20 hours 9 minutes ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 20 hours 9 minutes ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 6 hours ago Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo
